Serum lipoprotein profile and APOE genotype in Alzheimer's disease

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 175-179

  Cagnin, A ^a   Zambon, A ^b   Zarantonello, G ^a   Vianello, D ^b   Marchiori, M ^b   Mercurio, D ^a   Micciche F ^c   Ermani, M ^a   Leon, A ^c,d   Battistin, L ^a,d  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Research and Innovation   (Italy)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; APOE; cholesterol; LDL; lipid profile

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; COHORT ANALYSIS; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; REFERENCE VALUE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; TRIGLYCERIDES;

EID: 38449094369     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_22     Document Type: Article

References (27)

1. Bonarek M, Barberger-Gateau P, Letenneur L, Deschamps V, Iron A, Dubroca B, Dartigues JF (2000) Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepidemiology 19:141-148
2. Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A (2006) APOE genotype and cholesterol levels in Lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry 14:1022-1031
3. Chung BH, Wilkinson T, Geer JC, Segrest JP (1980) Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 21:284-291
4. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT (1986) Single vertical spin density gradient ultracentrifugation. In: Segrest JP, Albers JJ (eds) Methods in enzymology, plasma lipoproteins: preparation, structure, and molecular biology. Academic Press, San Diego 181-209
5. De la Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184-190
6. Dietschy JM, Turley SD (2004) Cholesterol metabolism in the central nervous system during early development and in mature animal. J Lipid Res 45:1375-1393
7. Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, Hendrie H (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 54:240-242
8. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators (2006) Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20:93-100
9. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
10. Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer's disease-epidemiological evidence. Acta Neurol Scand 114:50-57
11. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735-741
12. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 252:711-715
13. Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriat Cogn Disord 12:138-145
14. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545-551
15. McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
16. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoprotein E epsilon allele, and Alzheimer's disease. Neuroepidemiology 17:14-20
17. Ohm TG, Meske V (2006) Cholesterol, statins and tau. Acta Neurol Scand 114:93-101
18. Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51:275-292
19. Romas SN, Tang MX, Berglund L, Mayeux R (1999) APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 53:517-521
20. Shie FS, Jin LW, Cook DG, Leverenz JB, Le Boeuf RC (2002) Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13:455-459
21. Shobab LA, Hsiung G-YR, Feldman HH (2005) Cholesterol in Alzheimer's disease. Lancet Neurol 4:841-852
22. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. PNAS 95:6460-6464
23. Stampfer MJ (2006) Cardiovascular disease and Alzheimer's disease: common links. J Int Med 260:211-223
24. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel PD, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Int Med 163:1053-1057
25. Wahlund LO, Barkhof F, Fakezas F, Bronge L, Augustin M, Sjoegren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) On behalf of the European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318-1322
26. Wolozin B, Manger J, Bryant R, Cordy J, Green RC, McKee A (2006) Re-assessing the relationship between cholesterol, statins and Alzheimer's disease. Acta Neurol Scand 114 Suppl 185:63-70
27. Zlokovic VB (2005) Neurovascular mechanisms of Alzheimer's disease neurodegeneration. Trends Neurosci 28:202-208